Moxifloxacin Injection — FDA Drug Shortage

No longer listed by FDA — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Moxifloxacin Injection (injection) from Fresenius Kabi USA, LLC with status No longer listed by FDA. The shortage was first posted on Oct 29, 2025.

Shortage details

Status
No longer listed by FDA
Company
Fresenius Kabi USA, LLC
Package NDC
63323-850-74
Dosage Form
Injection
Presentation
Moxifloxacin, Injection, 400mg per 250mL (NDC 63323-850-74)
Initial Posting
Oct 29, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.